Production (Stage)
Aspire Biopharma Holdings, Inc.
ASBP
$0.225
$0.0010.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.35M | 3.60K | 16.50K | 19.60K | 11.20K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 619.00K | 144.40K | 167.50K | 30.00K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.97M | 148.00K | 184.00K | 49.60K | -- |
|
|
|||||
| Total Current Assets | 1.97M | 148.00K | 184.00K | 49.60K | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 5.01M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.97M | 148.00K | 184.00K | 5.06M | -- |
|
|
|||||
| Total Accounts Payable | 1.43M | 310.20K | 129.40K | 161.50K | -- |
| Total Accrued Expenses | 672.70K | -- | -- | -- | -- |
| Short-term Debt | 6.76M | 1.27M | 853.10K | 445.40K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 111.00K | 3.10K | 157.30K | -- |
| Total Other Current Liabilities | -- | 111.00K | 3.10K | 157.30K | -- |
| Total Current Liabilities | 8.87M | 1.69M | 985.60K | 764.30K | -- |
|
|
|||||
| Total Current Liabilities | 8.87M | 1.69M | 985.60K | 764.30K | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 6.76M | 1.27M | 853.10K | 445.40K | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 49.30K | -- | -- | 3.85M | -- |
| Total Liabilities | 8.92M | 1.69M | 985.60K | 4.62M | -- |
|
|
|||||
| Common Stock & APIC | 11.77M | 1.24M | 1.24M | 2.24M | -- |
| Retained Earnings | -18.72M | -2.78M | -2.04M | -1.80M | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -6.95M | -1.54M | -801.60K | 442.00K | -487.90K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 0.00 | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 0.00 | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.95M | -1.54M | -801.60K | 442.00K | -487.90K |
| Total Preferred Equity | -- | 0.00 | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.95M | -1.54M | -801.60K | 442.00K | -487.90K |
|
|
|||||